TRVHX
Price
$17.88
Change
-$0.32 (-1.76%)
Updated
Feb 21 closing price
Net Assets
1.84B
VMVAX
Price
$85.40
Change
-$0.97 (-1.12%)
Updated
Feb 21 closing price
Net Assets
30.89B
Ad is loading...

TRVHX vs VMVAX

Header iconTRVHX vs VMVAX Comparison
Open Charts TRVHX vs VMVAXBanner chart's image
Nuveen Mid Cap Value I
Price$17.88
Change-$0.32 (-1.76%)
VolumeN/A
Net Assets1.84B
Vanguard Mid-Cap Value Index Admiral
Price$85.40
Change-$0.97 (-1.12%)
VolumeN/A
Net Assets30.89B
TRVHX vs VMVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
TRVHX vs. VMVAX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRVHX is a Hold and VMVAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.9B vs. TRVHX (1.84B). VMVAX pays higher dividends than TRVHX: VMVAX (2.14) vs TRVHX (1.41). TRVHX was incepted earlier than VMVAX: TRVHX (9 years) vs VMVAX (13 years). TRVHX is a more actively managed with annual turnover of: 78.00 vs. VMVAX (22.00). VMVAX has a lower initial minimum investment than TRVHX: VMVAX (3000) vs TRVHX (100000). VMVAX annual gain was more profitable for investors over the last year : 12.44 vs. TRVHX (7.99). VMVAX return over 5 years is better than : 38.46 vs. TRVHX (6.66).
TRVHXVMVAXTRVHX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years13 years-
Gain YTD1.4181.92174%
Front LoadN/AN/A-
Min. Initial Investment10000030003,333%
Min. Initial Investment IRAN/AN/A-
Net Assets1.84B30.9B6%
Annual Yield % from dividends1.412.1466%
Returns for 1 year7.9912.4464%
Returns for 3 years1.5315.3410%
Returns for 5 years6.6638.4617%
Returns for 10 yearsN/A81.26-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DDI9.96-0.02
-0.20%
DoubleDown Interactive Co Ltd
MANU14.46-0.15
-1.03%
Manchester United PLC
SRPT106.28-2.13
-1.96%
Sarepta Therapeutics
FTK8.22-0.20
-2.38%
Flotek Industries
ARTL1.16-0.04
-3.33%
Artelo Biosciences